Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · IEX Real-Time Price · USD

10.39

-0.21 (-1.98%)

At close: May 15, 2024, 4:00 PM

10.37

-0.02 (-0.19%)

After-hours: May 15, 2024, 7:38 PM EDT

Avalo Therapeutics Market Cap

Avalo Therapeutics has a market cap or net worth of $10.74 million as of May 15, 2024. Its market cap has decreased by -69.12% in one year.

Market Cap

10.74M

Enterprise Value

-99.44M

1-Year Change

-69.12%

Ranking

#5207

Market Cap Chart

Since November 13, 2015, Avalo Therapeutics's market cap has decreased from $34.50M to $10.74M, a decrease of -68.86%. That is a compound annual growth rate of -12.81%.

Market Cap History

Date	Market Cap	% Change
May 14, 2024	11.00M	-1.79%
May 13, 2024	11.20M	28.74%
May 10, 2024	8.70M	-5.43%
May 9, 2024	9.20M	-2.13%
May 8, 2024	9.40M	-11.32%
May 7, 2024	10.60M	-1.85%
May 6, 2024	10.80M	-6.09%
May 3, 2024	11.50M	-6.50%
May 2, 2024	12.30M	-3.91%
May 1, 2024	12.80M	-6.57%
Apr 30, 2024	13.70M	1.48%
Apr 29, 2024	13.50M	5.47%
Apr 26, 2024	12.80M	6.67%
Apr 25, 2024	12.00M	5.26%
Apr 24, 2024	11.40M	9.62%
Apr 23, 2024	10.40M	6.12%
Apr 22, 2024	9.80M	5.38%
Apr 19, 2024	9.30M	-3.13%
Apr 18, 2024	9.60M	-11.93%
Apr 17, 2024	10.90M	-14.84%
Apr 16, 2024	12.80M	4.92%
Apr 15, 2024	12.20M	2.52%
Apr 12, 2024	11.90M	-5.56%
Apr 11, 2024	12.60M	4.13%
Apr 10, 2024	12.10M	4.31%

View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Elevai Labs	11.25M
Centogene	11.15M
Moleculin Biotech	11.14M
Guardion Health Sciences	11.10M
Can-Fite BioPharma	10.90M
BioCardia	10.74M
CareMax	10.72M
Genetic Technologies	10.71M

Market Cap Rankings